Manejo práctico de ustekinumab en la psoriasis moderada-grave
Practical management of ustekinumab in moderate-severe psoriasis
J. Notario
, X. Bordas
Autor para correspondencia
Servicio de Dermatología. Hospital Universitari de Bellvitge. L’Hospitalet de Llobregat. Barcelona. España
Leído
5034
Vecesse ha leído el artículo
2928
Total PDF
2106
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 63 | 112 | 175 |
| 2025 5 | 63 | 58 | 121 |
| 2025 4 | 50 | 33 | 83 |
| 2025 3 | 43 | 32 | 75 |
| 2025 2 | 39 | 38 | 77 |
| 2025 1 | 34 | 33 | 67 |
| 2024 12 | 25 | 27 | 52 |
| 2024 11 | 29 | 51 | 80 |
| 2024 10 | 23 | 42 | 65 |
| 2024 9 | 23 | 23 | 46 |
| 2024 8 | 40 | 54 | 94 |
| 2024 7 | 28 | 40 | 68 |
| 2024 6 | 29 | 39 | 68 |
| 2024 5 | 29 | 32 | 61 |
| 2024 4 | 20 | 21 | 41 |
| 2024 3 | 27 | 50 | 77 |
| 2024 2 | 22 | 31 | 53 |
| 2024 1 | 16 | 33 | 49 |
| 2023 12 | 14 | 20 | 34 |
| 2023 11 | 17 | 34 | 51 |
| 2023 10 | 19 | 25 | 44 |
| 2023 9 | 16 | 24 | 40 |
| 2023 8 | 13 | 12 | 25 |
| 2023 7 | 17 | 30 | 47 |
| 2023 6 | 8 | 25 | 33 |
| 2023 5 | 4 | 11 | 15 |
| 2023 4 | 22 | 23 | 45 |
| 2023 3 | 12 | 38 | 50 |
| 2023 2 | 16 | 20 | 36 |
| 2022 1 | 16 | 34 | 50 |
| 2022 12 | 23 | 36 | 59 |
| 2022 11 | 12 | 22 | 34 |
| 2022 10 | 18 | 32 | 50 |
| 2022 9 | 14 | 62 | 76 |
| 2022 8 | 16 | 52 | 68 |
| 2022 7 | 27 | 66 | 93 |
| 2022 6 | 10 | 40 | 50 |
| 2022 5 | 26 | 53 | 79 |
| 2022 4 | 21 | 48 | 69 |
| 2022 3 | 18 | 49 | 67 |
| 2022 2 | 17 | 38 | 55 |
| 2021 1 | 23 | 41 | 64 |
| 2021 12 | 16 | 50 | 66 |
| 2021 11 | 22 | 48 | 70 |
| 2021 10 | 21 | 57 | 78 |
| 2021 9 | 15 | 55 | 70 |
| 2021 8 | 28 | 37 | 65 |
| 2021 7 | 28 | 54 | 82 |
| 2021 6 | 15 | 32 | 47 |
| 2021 5 | 15 | 44 | 59 |
| 2021 4 | 45 | 49 | 94 |
| 2021 3 | 27 | 36 | 63 |
| 2021 2 | 24 | 38 | 62 |
| 2020 1 | 20 | 30 | 50 |
| 2020 12 | 16 | 11 | 27 |
| 2020 11 | 15 | 21 | 36 |
| 2020 10 | 9 | 16 | 25 |
| 2020 9 | 7 | 10 | 17 |
| 2020 8 | 11 | 29 | 40 |
| 2020 7 | 7 | 19 | 26 |
| 2020 6 | 16 | 15 | 31 |
| 2020 5 | 19 | 35 | 54 |
| 2020 4 | 9 | 12 | 21 |
| 2020 3 | 9 | 19 | 28 |
| 2019 12 | 0 | 3 | 3 |
| 2019 11 | 0 | 8 | 8 |
| 2019 10 | 0 | 1 | 1 |
| 2019 8 | 0 | 3 | 3 |
| 2019 7 | 0 | 5 | 5 |
| 2019 6 | 0 | 7 | 7 |
| 2019 5 | 0 | 13 | 13 |
| 2019 4 | 0 | 2 | 2 |
| 2019 3 | 0 | 1 | 1 |
| 2019 2 | 0 | 5 | 5 |
| 2018 12 | 0 | 2 | 2 |
| 2018 11 | 0 | 5 | 5 |
| 2018 10 | 0 | 1 | 1 |
| 2018 3 | 1 | 0 | 1 |
| 2018 2 | 13 | 3 | 16 |
| 2018 1 | 9 | 5 | 14 |
| 2017 12 | 23 | 7 | 30 |
| 2017 11 | 9 | 4 | 13 |
| 2017 10 | 13 | 9 | 22 |
| 2017 9 | 5 | 13 | 18 |
| 2017 8 | 8 | 13 | 21 |
| 2017 7 | 10 | 3 | 13 |
| 2017 6 | 19 | 56 | 75 |
| 2017 5 | 18 | 17 | 35 |
| 2017 4 | 23 | 7 | 30 |
| 2017 3 | 19 | 27 | 46 |
| 2017 2 | 17 | 5 | 22 |
| 2016 1 | 17 | 14 | 31 |
| 2016 12 | 23 | 7 | 30 |
| 2016 11 | 25 | 5 | 30 |
| 2016 10 | 42 | 13 | 55 |
| 2016 9 | 35 | 14 | 49 |
| 2016 8 | 35 | 26 | 61 |
| 2016 7 | 27 | 20 | 47 |
| 2016 6 | 0 | 12 | 12 |
| 2016 5 | 1 | 20 | 21 |
| 2016 4 | 0 | 3 | 3 |
| 2016 3 | 0 | 3 | 3 |
| 2016 2 | 0 | 3 | 3 |
| 2015 1 | 1 | 25 | 26 |
| 2015 12 | 2 | 14 | 16 |
| 2015 11 | 5 | 21 | 26 |
| 2015 10 | 5 | 13 | 18 |
| 2015 9 | 2 | 12 | 14 |
| 2015 8 | 2 | 8 | 10 |
| 2015 7 | 26 | 2 | 28 |
| 2015 6 | 25 | 14 | 39 |
| 2015 5 | 42 | 22 | 64 |
| 2015 4 | 37 | 16 | 53 |
| 2015 3 | 35 | 10 | 45 |
| 2015 2 | 35 | 13 | 48 |
| 2015 1 | 25 | 13 | 38 |
| 2014 12 | 19 | 22 | 41 |
| 2014 11 | 26 | 16 | 42 |
| 2014 10 | 22 | 25 | 47 |
| 2014 9 | 0 | 1 | 1 |
| 2014 8 | 1 | 0 | 1 |
| 2014 7 | 0 | 1 | 1 |
| 2014 2 | 1 | 0 | 1 |
| 2014 1 | 1 | 2 | 3 |
| 2013 10 | 1 | 0 | 1 |
| 2013 9 | 0 | 1 | 1 |
| 2013 6 | 2 | 4 | 6 |
| 2013 5 | 1 | 2 | 3 |
| 2013 4 | 1 | 1 | 2 |
| 2013 3 | 1 | 1 | 2 |
| 2013 2 | 0 | 2 | 2 |
| 2013 1 | 0 | 1 | 1 |
Mostrar todo
